Heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
Abstract:
The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.
Information query
Patent Agency Ranking
0/0